Rankings
▼
Calendar
MESO FY 2014 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$26M
-9.7% YoY
Gross Profit
$546,000
2.1% margin
Operating Income
-$72M
-278.6% margin
Net Income
-$81M
-311.6% margin
EPS (Diluted)
$-1.50
Cash Flow
Operating Cash Flow
-$82M
Free Cash Flow
-$120M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$899M
Total Liabilities
$328M
Stockholders' Equity
$572M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$26M
$29M
-9.7%
Gross Profit
$546,000
$8M
-92.7%
Operating Income
-$72M
-$60M
-20.5%
Net Income
-$81M
-$62M
-31.3%
← FY 2013
All Quarters
FY 2015 →